EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fusion of histone variants to Cas9 suppresses non-homologous end joining

Tomoko Kato-Inui, Gou Takahashi iD, Terumi Ono, Yuichiro Miyaoka iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0288578 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Tomoko Kato-Inui und 3 weiteren Autor:innen. Beteiligte Einrichtung: Tokyo Metropolitan Institute of Medical Science, Regenerative Medicine Project, Tokyo, Japan. Hauptthemen laut MEDLINE: Histones, DNA End-Joining Repair, CRISPR-Associated Protein 9, CRISPR-Cas Systems. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Takeda Science Foundation, Uehara Memorial Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As a versatile genome editing tool, the CRISPR-Cas9 system induces DNA double-strand breaks at targeted sites to activate mainly two DNA repair pathways: HDR which allows precise editing via recombination with a homologous template DNA, and NHEJ which connects two ends of the broken DNA, which is often accompanied by random insertions and deletions. Therefore, how to enhance HDR while suppressing NHEJ is a key to successful applications that require precise genome editing. Histones are small proteins with a lot of basic amino acids that generate electrostatic affinity to DNA. Since H2A.X is involved in DNA repair processes, we fused H2A.X to Cas9 and found that this fusion protein could improve the HDR/NHEJ ratio by suppressing NHEJ. As various post-translational modifications of H2A.X play roles in the regulation of DNA repair, we also fused H2A.X mimicry variants to replicate these post-translational modifications including phosphorylation, methylation, and acetylation. However, none of them were effective to improve the HDR/NHEJ ratio. We further fused other histone variants to Cas9 and found that H2A.1 suppressed NHEJ better than H2A.X. Thus, the fusion of histone variants to Cas9 is a promising option to enhance precise genome editing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HistonesDNA End-Joining RepairCRISPR-Associated Protein 9CRISPR-Cas SystemsGene EditingHumansProtein Processing, Post-TranslationalDNA Breaks, Double-StrandedRecombinant Fusion ProteinsHEK293 CellsAcetylation

Substanzen

HistonesCRISPR-Associated Protein 9Recombinant Fusion Proteins

Autor:innen und Institutionen

  • Tokyo Metropolitan Institute of Medical Science, Regenerative Medicine Project, Tokyo, Japan.
  • Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
  • Graduate School of Humanities and Sciences, Ochanomizu University, Tokyo, Japan.

ORCID-Profile: Gou Takahashi, Yuichiro Miyaoka

Förderung

  • Japan Society for the Promotion of Science
  • Takeda Science Foundation
  • Uehara Memorial Foundation

Zitieren

APA

Kato-Inui, T., Takahashi, G., Ono, T., & Miyaoka, Y. (2024). Fusion of histone variants to Cas9 suppresses non-homologous end joining. PLOS ONE. https://doi.org/10.1371/journal.pone.0288578

Vancouver

Kato-Inui T, Takahashi G, Ono T, Miyaoka Y. Fusion of histone variants to Cas9 suppresses non-homologous end joining. PLOS ONE. 2024. doi:10.1371/journal.pone.0288578

BibTeX
@article{KatoInui2024,
  author = {Kato-Inui, Tomoko and Takahashi, Gou and Ono, Terumi and Miyaoka, Yuichiro},
  title = {Fusion of histone variants to Cas9 suppresses non-homologous end joining},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0288578}
}
Kostenlos starten →